After doing deals with big pharma — Eli Lilly and Co., Merck & Co. Inc., Abbvie Inc. and Bayer AG — Atomwise Inc. announced three partnerships last week with smaller preclinical companies to use its artificial intelligence (AI) platform to develop drugs for their targets. Read More
Although various government incentives have been introduced in the past few years to encourage and support more research and development designed to accelerate the discovery of new antibiotics, they, in themselves, have not been enough. Read More
